UnitedHealth Group is partnering with Eli Lilly to test the efficacy of its COVID-19 monoclonal antibody treatment, bamlanivimab, for patients at high risk of adverse outcomes. Bamlanivimab has not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback